Forecasting Returns When Patents Expire

From 2011 to 2015, patent exclusivity will expire for drugs totaling more than $140 billion in sales. This staggering number has drawn much of the industry’s attention to the impact on top-line sales. Yet the risk of unexpected product returns […]

Read More

The Changing Face of Today’s PAPs

Established to provide access to critical therapies for patients who cannot afford to pay, and to support the physicians who serve them, charitable patient-assistance programs (PAPs) sponsored by drug manufacturers have become an essential component in the healthcare safety net. […]

Read More